Charles River Laboratories Intl (CRL) 84.42 $CRL Charles

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Charles River Laboratories Intl (CRL) 84.42 $CRL

Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium
BusinessWire - Mon Aug 08, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium.
GSK: 44.26 (+1.28), CRL: 84.42 (+0.82)

Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations
BusinessWire - Wed Aug 03, 6:00AM CDT
--- Second-Quarter GAAP Earnings per Share of $0.73
CRL: 84.42 (+0.82)

Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:36AM CDT
The Medical sector is expected to deliver 5.4% earnings growth on 10.5% higher revenues in the second quarter.
PRXL: 68.70 (+0.36), EVHC: 22.18 (+0.73), CRL: 84.42 (+0.82), HUM: 177.33 (+0.80)

Charles River Laboratories to Present at Jefferies and William Blair Conferences
BusinessWire - Mon Jun 06, 7:30AM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York on Wednesday, June 8th, at 10:00 a.m. EDT, and the William Blair 36th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 14th, at 1:30 p.m. CDT (2:30 p.m. EDT). Management will present an overview of Charles River's strategic focus and business developments.
CRL: 84.42 (+0.82)

Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna's Nonclinical Development Efforts for Novel mRNA Therapeutics
BusinessWire - Mon Jun 06, 7:00AM CDT
Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics(TM) and Charles River Laboratories International, Inc. (NYSE:CRL), a leading early-stage contract research organization (CRO), today announced a strategic collaboration to support Moderna's nonclinical discovery and development efforts. Charles River will be a key partner as Moderna continues to grow and advance its pipeline spanning multiple drug modalities and therapeutic areas, conducting nonclinical activities to progress development candidates through investigational new drug (IND)-enabling studies and into the clinic.
CRL: 84.42 (+0.82)

Charles River beats Street 1Q forecasts
Automated Insights - Wed May 04, 6:20AM CDT
WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported first-quarter earnings of $37.1 million.
CRL: 84.42 (+0.82)

Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations
BusinessWire - Wed May 04, 6:00AM CDT
--- First-Quarter GAAP Earnings per Share of $0.78and Non-GAAP Earnings per Share of $0.98 -
CRL: 84.42 (+0.82)

The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International
AIRM: 35.79 (+0.90), PRXL: 68.70 (+0.36), EBS: 26.90 (+0.49), CRL: 84.42 (+0.82), MOH: 55.33 (+1.79)

5 Stocks to Invest on Healthcare Rebound
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 10:42AM CDT
Healthcare stocks bounced back this month after being mostly out of favor during the first quarter.
AIRM: 35.79 (+0.90), PRXL: 68.70 (+0.36), EBS: 26.90 (+0.49), CRL: 84.42 (+0.82), MOH: 55.33 (+1.79)

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call
BusinessWire - Thu Apr 07, 3:30PM CDT
Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4th before the market opens. A conference call has been scheduled to discuss this information on Wednesday, May 4th, at 8:30 a.m. ET.
CRL: 84.42 (+0.82)

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance
BusinessWire - Wed Feb 10, 6:00AM CST
--- Fourth-Quarter GAAP Earnings per Share of $0.69 and Non-GAAP Earnings per Share of $1.00 -
CRL: 84.42 (+0.82)

PAREXEL International Q2 Earnings Beat, FY16 View Slashed
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 8:00AM CST
PAREXEL International Corp (PRXL) reported adjusted earnings of 90 cents per share in the second quarter of fiscal 2016, beating the Zacks Consensus Estimate by 19 cents.
PRXL: 68.70 (+0.36), INCR: 44.01 (+0.19), AHS: 36.25 (+0.57), CRL: 84.42 (+0.82)

Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
Zacks Equity Research - Zacks Investment Research - Fri Jan 22, 8:30AM CST
Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
AIRM: 35.79 (+0.90), INCR: 44.01 (+0.19), HWAY: 24.96 (+0.10), AHS: 36.25 (+0.57), CRL: 84.42 (+0.82)

Top Healthcare Stocks
Brian Bolan - ZACKS - Thu Jan 21, 2:17PM CST
Top Healthcare Stocks
AIRM: 35.79 (+0.90), HWAY: 24.96 (+0.10), INCR: 44.01 (+0.19), AHS: 36.25 (+0.57), CRL: 84.42 (+0.82)

Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference Call
BusinessWire - Wed Jan 20, 3:30PM CST
Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2015 financial results and provide 2016 guidance on Wednesday, February 10th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 10th, at 8:30 a.m. ET.
CRL: 84.42 (+0.82)

New Strong Buy Stocks for January 19th
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
CNC: 68.62 (+1.28), CBG: 30.17 (+0.28), AAL: 36.53 (+0.29), CRL: 84.42 (+0.82), CAFD: 15.56 (+0.01)

Upgrade Alert for Charles River Laboratories (CRL)
Comtex SmarTrend(R) - Fri Jan 08, 7:15AM CST
Charles River Laboratories (NYSE:CRL) was upgraded from Market Perform to Outperform at Wells Fargo today. The stock closed yesterday at $78.52 on volume of 1.2 million shares, above average daily volume of 389,000. Based on a current price of $78.52, Charles River Laboratories is currently 0.4% above its average consensus analyst price target of $78.21. The stock should find initial support at its 50-day moving average (MA) of $75.24 and further support at its 200-day MA of $72.90.
CRL: 84.42 (+0.82)

BUYINS.NET: CVV, ISRG, CCG, RUSHA, CRL, CIU Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jan 08, 6:38AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Canalaska Uranium Ltd (NASDAQ:CVV), Intuitive Surgical Inc (NASDAQ:ISRG), Campus Crest Communities Inc (NYSE:CCG), Rush Enterprises Inc (NASDAQ:RUSHA), CHARLES RIVER LABORATORIES INTERNATIONAL INC (NYSE:CRL), Ishares Barclays Intermediate Credit Bond Fund (NYSE:CIU) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ISRG: 688.37 (-1.32), CVV: 8.58 (+0.06), CRL: 84.42 (+0.82), RUSHB: 23.75 (-0.28), CIU: 111.29 (+0.02), RUSHA: 23.54 (+0.07), CCG: 7.00 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 45

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 106

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 52

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Panasonic Showcases Rugged Tech at NATO Edge 26

Updated Category News Views 56

Panasonic Heads to Turkey with Tactical Tech Panasonic's got its sights set on proving a point at NATO Edge 26, busting out its TOUGHBOOK line and showing just how these rugged laptops aren't just tough, but also strategically essential. From November 17th through 19th, down in Turkey, these devices are taking the spotlight as they embrace the operational challenges of...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 111

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 77

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 45

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 83

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading

Top 5 Most Recently Viewed Articles

Blain’s Farm & Fleet Shines in Newsweek’s Best Online Shops

Updated Category News Views 97

Blain’s Farm & Fleet Achieves Recognition for Online Excellence Blain's Farm & Fleet, a well-respected name in retail, has been honored as one of Newsweek’s Best Online Shops for 2025. This recognition marks the fourth consecutive year the company has earned this prestigious title, reflecting its unwavering commitment to quality and service across its online platform....

Continue Reading
Statkraft AS Secures NOK 3 Billion Through Commercial Paper

Updated Category News Views 127

Statkraft AS Secures Significant Funding Statkraft AS has successfully issued a commercial paper totaling NOK 3.0 billion, showcasing the company's strategic approach to financing. This financial instrument offers a coupon rate of 3M NIBOR plus 0.205%, reflecting favorable conditions in financial markets. Details of the Commercial Paper The commercial paper is designed...

Continue Reading
Soleno Therapeutics Launches $100 Million Stock Buyback Program

Updated Category News Views 143

Soleno Therapeutics Initiates Major Buyback Program Soleno Therapeutics Inc. (NASDAQ: SLNO) has announced a significant development in its corporate strategy by launching a $100 million share repurchase program. This move comes as the company seeks to enhance shareholder value amidst an environment where its stock has been deemed undervalued by market analysts. Details of...

Continue Reading
Brentwood Associates Launches $410 Million Fund for Watermill

Updated Category News Views 383

Overview of the New Continuation Fund Brentwood Associates, a leading private equity firm known for its strategic and growth-oriented investments, has officially closed an impressive $410 million continuation fund aimed at fueling the expansion of Watermill Express, LLC. This fund's purpose is to enhance the operational capabilities of Watermill Express, a prominent...

Continue Reading
Great Lakes Dredge & Dock Corporation Upgraded to B- Rating

Updated Category News Views 105

Great Lakes Dredge & Dock Corporation Receives S&P Upgrade Great Lakes Dredge & Dock Corporation ("Great Lakes" or the “Company”) (NASDAQ: GLDD), the leading provider of dredging services in the United States, has announced a notable upgrade to its issuer credit rating by S&P Global Ratings. The rating has been elevated from “CCC+” to “B-,” signaling a...

Continue Reading